Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21

Annals of Hematology

Volumn 89, Issue 1, 2010, Pages 1-7

  Kizildag, Sefa ^a   Ates, Halil ^a   Kizildag, Servet ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

1 ,25 Dihydroxyvitamin D3; Apoptosis; K562

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P21;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN K 562; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CALCITRIOL; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; K562 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; UP-REGULATION;

EID: 71349088729     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0766-y     Document Type: Article

References (38)

1. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture Endocrinology 108 1083 1086 10.1210/endo-108-3-1083 1:CAS:528:DyaL3MXhtlaksLo%3D 6257495
2. 3 Proc Natl Acad Sci U S A 78 4990 4994 10.1073/pnas.78.8.4990 10.1073/pnas.78.8.4990 1:CAS:528:DyaL3MXlvFOqsrs%3D 6946446 (Pubitemid 12225607)
3. 3 analog (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells Cancer Res 56 3570 3576
4. KW Colston SK Chander AG Mackay RC Coombes 1992 Effects of synthetic vitamin D analogs of breast cancer cell proliferation in vivo and in vitro Biochem Pharmacol 44 693 702 10.1016/0006-2952(92) 90405-8 10.1016/0006-2952(92) 90405-8 1:CAS:528:DyaK38Xls1enur4%3D 1324683
5. 3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis Int J Cancer 61 806 811 10.1002/ijc.2910610611 10.1002/ijc.2910610611 1:CAS:528:DyaK2MXnt1CjsLw%3D 7790115
6. KW Colston AG Mackay SY James L Binderup 1992 EB1089, a new vitamin D analog that inhibits the growth of breast cancer cells in vivo and in vitro Biochem Pharmacol 44 2273 2280 10.1016/0006-2952(92) 90669-A 10.1016/0006-2952(92)90669-A 1:CAS:528:DyaK3sXhtFKqtro%3D 1472092
7. 3 and prostate cancer cell proliferation in vivo Urology 46 365 369 10.1016/S0090-4295(99) 80221-0 10.1016/S0090-4295(99)80221-0 1:STN:280:DyaK2MzovFGksQ%3D%3D 7660511
8. 3 and 19-nor-1, 25-dihydroxyvitamin D2 as therapeutics agents for prostate cancer Clin Cancer Res 6 901 908 1:CAS:528:DC%2BD3cXisVaqtbs%3D 10741714
9. 3 stimulates apoptosis in CaCo-2 cells Gastroenterology 112 A608
10. AM Saulenas SM Cohen LL Key C Winter DM Albert 1988 Vitamin D and retinoblastoma: the presence of receptors and inhibition of growth in vitro Arch Ophthalmol 106 533 535 10.1016/0002-9394(88) 90581-8 10.1016/0002-9394(88) 90581-8 1:CAS:528:DyaL1cXksV2is7o%3D 2833210
11. MR Haussler GK Whitfield CA Haussler, et al. 1998 The nuclear vitamin D receptor: biological and molecular regulatory properties revealed J Bone Miner Res 13 325 349 10.1359/jbmr.1998.13.3.325 10.1359/jbmr.1998.13.3.325 1:CAS:528:DyaK1cXhvFGmtbk%3D 9525333 (Pubitemid 28146215)
12. LL Issa GM Leong JA Eisman 1998 Molecular mechanism of vitamin D receptor action Inflamm Res 47 451 475 10.1007/s000110050360 10.1007/s000110050360 1:CAS:528:DyaK1MXitlGmtg%3D%3D 9892040 (Pubitemid 29015635)
13. 3 and its analog, EB1089, in human breast cancer cells Oncogene 15 1555 1563 10.1038/sj.onc.1201329 10.1038/sj.onc.1201329 1:CAS:528:DyaK2sXmslynt7Y%3D 9380407
14. 3 analog, EB1089 on G1 cell cycle regulatory proteins in HL-60 cells Int J Oncol 16 315 320 1:CAS:528:DC%2BD3cXnvF2mtQ%3D%3D 10639575
15. 3 leads to the induced differentiation of the myelocytic cell line U937 Genes Dev 10 142 153 10.1101/gad.10.2.142 10.1101/gad.10.2.142 1:CAS:528:DyaK28XotlKnsA%3D%3D 8566748
16. 3 on G1-S phase controlling machinery Mol Endocrinol 15 1370 1380 10.1210/me.15.8.1370 10.1210/me.15.8.1370 1:CAS:528:DC%2BD3MXlslSgsbk%3D 11463860 (Pubitemid 32703484)
17. PH Reitsma PG Rothberg SM Astrin J Trial Z Bar-Shavit A Hall SL Teitelbaum AJ Kahn 1983 Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite Nature 306 492 494 10.1038/306492a0 10.1038/306492a0 1:CAS:528:DyaL2cXjtlGrsw%3D%3D 6689055
18. MM Kasten A Giordano 1998 pRb and the cdks in apoptosis and the cell cycle Cell Death Differ 5 132 140 10.1038/sj.cdd.4400323 10.1038/sj.cdd.4400323 1:CAS:528:DyaK1cXhtlGisLk%3D 10200457
19. C Mørk Hansen KJ Hamberg E Binderup L Binderup 2000 Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation Current Pharmaceutical Design 6 881 906
20. 3 and vitamin D analogs Curr Pharm Des 6 717 732 10.2174/1381612003400498 10.2174/1381612003400498 10828303
21. D Feldman X-Y Zhao AV Krishnan 2000 Vitamin D and prostate cancer Endocrinology 141 5 9 10.1210/en.141.1.5 10.1210/en.141.1.5 1:CAS:528: DC%2BD3cXkslak 10614617 (Pubitemid 32260339)
22. BB Lozzio CB Lozzio 1977 Properties of the K562 cell line derived from a patient with chronic myeloid leukemia Int J Cancer 19 136 143 10.1002/ijc.2910190119 10.1002/ijc.2910190119 1:STN:280:DyaE2s%2FptlSntA%3D%3D 264472
23. 3 of chemically induced erythroid differentiation of K562 leukemia cells Blood 77 1452 1461 1:CAS:528:DyaK3MXisVSju7o%3D 1849032
24. 3: towards an endocrine therapy of brain tumors J Neurosci Res 37 271 277 10.1002/jnr.490370212 10.1002/jnr.490370212 1:CAS:528:DyaK2cXhsFCrsLw%3D 8151734
25. 3 and its analog EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy Cancer Res 60 2304 2312 1:CAS:528:DC%2BD3cXivVakt74%3D 10786699
26. IS Mathiasen U Lademann M Jaattela 1999 Apoptosis induced by vitamin D compounds in breast cancer is inhibited by Bcl-2 but doesn't involve known caspases or p53 Cancer Res 59 4848 4856 1:CAS:528:DyaK1MXmslWkt7c%3D 10519395
27. 3 Cancer Res 52 515 520 1:CAS:528:DyaK38Xht1Grur4%3D 1370648
28. 3 inhibits the invasive potential of human breast cancer cells in vitro Clin. Exp. Metas. 12 195 202 10.1007/BF01753887 10.1007/BF01753887 (Pubitemid 24196028)
29. KW Colston C Hansen 2002 Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer Endocr Relat Cancer 9 45 59 10.1677/erc.0.0090045 10.1677/erc.0.0090045 1:CAS:528:DC%2BD38XjsVCltb4%3D 11914182 (Pubitemid 34298363)
30. S Chen Y Xue X Zhang Y Wu J Pan Y Wang J Ceng 2005 A new human acute monocytic leukemia cell line SHI-1 with t(6;11)(q27;q23) gene alteration and high tumorigenicity in nude mice Hematologia 90 766 775 1:CAS:528: DC%2BD2MXnvVWku7w%3D
31. 3 analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27 Exp Cell Res 254 279 286 10.1006/excr.1999.4735 10.1006/excr.1999.4735 1:CAS:528:DC%2BD3cXksl2rsw%3D%3D 10640426 (Pubitemid 30080584)
32. 3-induced G1 to S phase block in polyploid HL60 cells J Cell Physiol 168 18 25 10.1002/(SICI) 1097-4652(199607) 168:1<18::AID-JCP3>3.0.CO;2-B 10.1002/(SICI)1097-4652(199607)168:1<18::AID-JCP3>3.0.CO;2-B 1:CAS:528:DyaK28XjvVSqu7g%3D 8647913
33. 3 precedes the G1/G0 phase cell cycle block Cell Prolif 27 643 654 10.1111/j.1365-2184.1994.tb01379.x 10.1111/j.1365-2184.1994.tb01379.x 1:CAS:528:DyaK2MXivFagurc%3D
34. G Pirianov KW Colston 2001 Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells Steroids 66 309 318 10.1016/S0039-128X(00) 00201-4 10.1016/S0039-128X(00)00201-4 1:CAS:528:DC%2BD3MXhtFehtrY%3D 11179739
35. CJ Narvaez J Welsh 2001 Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells J Biol Chem 276 9101 9107 10.1074/jbc.M006876200 10.1074/jbc.M006876200 1:CAS:528:DC%2BD3MXisVCnurY%3D 11053435
36. 3 analogue EB 1089 in NCI-H929 myeloma cells via activation of caspase and MAP kinase Br J Haematol 109 576 583 10.1046/j.1365-2141.2000.02046.x 10.1046/j.1365-2141.2000. 02046.x 1:CAS:528:DC%2BD3cXkvVWktL4%3D 10886207 (Pubitemid 30415185)
37. SE Blutt TJ McDonnell TC Polek NL Weigel 2000 Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2 Endocrinology 141 10 17 10.1210/en.141.1.10 10.1210/en.141.1.10 1:CAS:528:DC%2BD3cXkslar 10614618 (Pubitemid 32260340)
38. JY Yang X Liu K Bhalla C Naekyung Kim AM Ibrado J Cai T-I Peng DP Jones X Wang 1997 Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondrial blocked Science 275 1129 1132 10.1126/science.275.5303.1129 10.1126/science.275.5303.1129 1:CAS:528:DyaK2sXhtlKjs70%3D 9027314 (Pubitemid 27097312)